Amanote Research
Register
Sign In
242 Long-Term Prognosis of Patients With Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension: Cstar-Pah Cohort Study
doi 10.1136/lupus-2017-000215.242
Full Text
Open PDF
Abstract
Available in
full text
Date
March 1, 2017
Authors
J Zhao
J Qian
W Qian
M Li
X Zeng
Publisher
Lupus Foundation of America
Related search
244 Long-Term Prognosis and Predicting Factors of Chinese Patients With Systemic Lupus Erythematosus: A Multi-Centrecenter Cohort Study From Cstar Registry
The Prevalence and Features of Ultrasound Pulmonary Arterial Hypertension in Patients With Systemic Lupus Erythematosus
Balneo Research Journal
Pulmonary Hypertension in Systemic Lupus Erythematosus
Advances in Pulmonary Hypertension
Pulmonary Arterial Hypertension Associated With Systemic Lupus: Results From the French Pulmonary Hypertension Registry
Chest
Cardiology
Critical Care
Cardiovascular Medicine
Intensive Care Medicine
Pulmonary
Respiratory Medicine
Withdrawal of Long-Term Epoprostenol Therapy in Pulmonary Arterial Hypertension (PAH)
Pulmonary Circulation
Pulmonary
Respiratory Medicine
Systemic Lupus Erythematosus and Pulmonary Arterial Hypertension: Links, Risks, and Management Strategies
Open Access Rheumatology: Research and Reviews
Rheumatology
Remission of Precapillary Pulmonary Hypertension in Systemic Lupus Erythematosus
Journal of the Royal Society of Medicine
Medicine
EXPRESS: The Clinical Characteristics and Long-Term Prognosis of Pulmonary Arterial Hypertension Associated With Hereditary Hemorrhagic Telangiectasia
Pulmonary Circulation
Pulmonary
Respiratory Medicine
Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
Chest
Cardiology
Critical Care
Cardiovascular Medicine
Intensive Care Medicine
Pulmonary
Respiratory Medicine
